Safety, Reactogenicity and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adults, Children, Older Infants and Infants
This study has been completed.
Sponsor:
Novartis Vaccines Institute for Global Health
Information provided by (Responsible Party):
Novartis Vaccines Institute for Global Health
ClinicalTrials.gov Identifier:
NCT01229176
First received: October 25, 2010
Last updated: September 19, 2012
Last verified: September 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | June 2012 |
| Primary Completion Date: | June 2012 (Final data collection date for primary outcome measure) |